全文获取类型
收费全文 | 567篇 |
免费 | 43篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 9篇 |
妇产科学 | 9篇 |
基础医学 | 53篇 |
口腔科学 | 42篇 |
临床医学 | 44篇 |
内科学 | 108篇 |
皮肤病学 | 13篇 |
神经病学 | 13篇 |
特种医学 | 15篇 |
外科学 | 139篇 |
综合类 | 23篇 |
预防医学 | 40篇 |
眼科学 | 7篇 |
药学 | 20篇 |
肿瘤学 | 73篇 |
出版年
2021年 | 6篇 |
2020年 | 5篇 |
2019年 | 14篇 |
2018年 | 15篇 |
2017年 | 9篇 |
2016年 | 5篇 |
2015年 | 20篇 |
2014年 | 24篇 |
2013年 | 29篇 |
2012年 | 30篇 |
2011年 | 28篇 |
2010年 | 22篇 |
2009年 | 11篇 |
2008年 | 25篇 |
2007年 | 22篇 |
2006年 | 21篇 |
2005年 | 9篇 |
2004年 | 16篇 |
2003年 | 11篇 |
2002年 | 12篇 |
2001年 | 5篇 |
1999年 | 11篇 |
1998年 | 4篇 |
1997年 | 11篇 |
1996年 | 4篇 |
1995年 | 8篇 |
1993年 | 4篇 |
1992年 | 10篇 |
1990年 | 9篇 |
1989年 | 8篇 |
1987年 | 6篇 |
1986年 | 8篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1981年 | 3篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 12篇 |
1976年 | 16篇 |
1975年 | 12篇 |
1974年 | 11篇 |
1973年 | 11篇 |
1972年 | 13篇 |
1971年 | 12篇 |
1970年 | 14篇 |
1969年 | 5篇 |
1967年 | 4篇 |
1966年 | 3篇 |
1965年 | 3篇 |
1964年 | 4篇 |
排序方式: 共有610条查询结果,搜索用时 15 毫秒
1.
M. Cornely 《Archives of gynecology and obstetrics》1987,242(1-4):686-688
Ohne Zusammenfassung 相似文献
2.
We followed 18,490 infants from their first visit to a county child health clinic (CHC) in Maryland through visits through their third year of age to investigate whether their continued use of the CHCs was related to their characteristics or to the services they were provided as an infant. We classified as provided services immunization, an Early and Periodic Screening, Diagnosis, and Treatment Program (EPSDT) recommended screening, and number of visits. Immunization was associated with an increased percentage of infants who returned to the CHCs at two and three years of age. Half of the children, on the other hand, never returned to the clinics if they were not immunized as infants. These findings persisted, regardless of race, Medicaid status, completion of a screening, or number of visits in the first year of life. One-fifth of infants did not receive an immunization during one or more visits to CHCs in their first year. Failure to administer an immunization to infants appears to impede subsequent use of public health clinics for well child care. 相似文献
3.
Oscillatory motion of the normal cervical spinal cord 总被引:2,自引:0,他引:2
4.
5.
Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations 总被引:9,自引:1,他引:9
Meyer J; Sudbeck P; Held M; Wagner T; Schmitz ML; Bricarelli FD; Eggermont E; Friedrich U; Haas OA; Kobelt A; Leroy JG; Van Maldergem L; Michel E; Mitulla B; Pfeiffer RA; Schinzel A; Schmidt H; Scherer G 《Human molecular genetics》1997,6(1):91-98
It has previously been shown that, in the heterozygous state, mutations in
the SOX9 gene cause campomelic dysplasia (CD) and the often associated
autosomal XY sex reversal. In 12 CD patients, 10 novel mutations and one
recurrent mutation were characterized in one SOX9 allele each, and in one
case, no mutation was found. Four missense mutations are all located within
the high mobility group (HMG) domain. They either reduce or abolish the
DNA-binding ability of the mutant SOX9 proteins. Among the five nonsense
and three frameshift mutations identified, two leave the C-terminal
transactivation (TA) domain encompassing residues 402-509 of SOX9 partly or
almost completely intact. When tested in cell transfection experiments, the
recurrent nonsense mutation Y440X, found in two patients who survived for
four and more than 9 years, respectively, exhibits some residual
transactivation ability. In contrast, a frameshift mutation extending the
protein by 70 residues at codon 507, found in a patient who died shortly
after birth, showed no transactivation. This is apparently due to
instability of the mutant SOX9 protein as demonstrated by Western blotting.
Amino acid substitutions and nonsense mutations are found in patients with
and without XY sex reversal, indicating that sex reversal in CD is subject
to variable penetrance. Finally, none of 18 female patients with XY gonadal
dysgenesis (Swyer syndrome) showed an altered SOX9 banding pattern in SSCP
assays, providing evidence that SOX9 mutations do not usually result in XY
sex reversal without skeletal malformations.
相似文献
6.
Cornely PB 《Urban health》1976,5(2):32, 55-32, 56
7.
Effect of genetic modification of acute inflammatory responsiveness on tumorigenesis in the mouse 总被引:1,自引:3,他引:1
8.
Daniele Roberto Giacobbe Juergen Prattes Joost Wauters Silvia Dettori Alessio Signori Jon Salmanton-García Johan Maertens Marc Bourgeois Marijke Reynders Lynn Rutsaert Niels Van Regenmortel Piet Lormans Simon Feys Nikolay Klimko Olga Shadrivova Oliver A. Cornely Riina Rautemaa-Richardson Philipp Koehler Katrien Lagrou Matteo Bassetti Martin Hoenigl 《Journal of clinical microbiology》2022,60(4)
9.
Oliver A. Cornely Thomas M. File Lynne Garrity-Ryan Surya Chitra Robert Noble Paul C. McGovern 《International journal of antimicrobial agents》2021,57(2):106263
BackgroundMany antibiotics require dosage adjustments in patients with renal impairment. In Phase III studies, omadacycline was non-inferior to moxifloxacin and linezolid in adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), respectively. This analysis evaluated efficacy and safety measures from three omadacycline studies by patient renal function.MethodsPatients were stratified as having normal renal function (creatinine clearance >89 mL/min), mild renal impairment (creatinine clearance 60–89 mL/min) or moderate renal impairment (creatinine clearance <60 mL/min); creatine clearance ≤30 mL/min (severe renal impairment) was an exclusion criterion. Efficacy endpoints were clinical success at the early clinical response (ECR) and post-treatment evaluation (PTE) time-points. Safety was evaluated as treatment-emergent adverse events (TEAEs) and laboratory measures.ResultsThis subgroup analysis included 773 patients with CABP and 1339 patients with ABSSSI in intent-to-treat (ITT) and modified ITT populations, respectively. Clinical success rates were high at ECR and PTE across the studies (CABP 75–90%; ABSSSI 74–95%), and broadly similar between treatments, irrespective of renal function. Rates of TEAEs in patients with ABSSSI ranged from 33% to 52%, and were similar across renal function groups. In patients with CABP, higher rates were observed in patients with moderate renal impairment (56–61%) compared with patients with normal renal function or mild renal impairment (35–49%). The most common TEAEs were nausea and vomiting.ConclusionsClinical success was similar across renal function groups, indicating no notable difference in the efficacy of omadacycline in patients with mild or moderate renal impairment. Omadacycline and comparators displayed similar safety profiles.ClinicalTrials.gov registryOPTIC (NCT02531438); OASIS-1 (NCT02378480); OASIS-2 (NCT02877927). 相似文献
10.